Legal & General Group
IRWD icon

Legal & General Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Legal & General Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.2K Sell
14,288
-2,402
-14% -$9.85K ﹤0.01% 2681
2025
Q4 		$56.2K Sell
16,690
-1,669
-9% -$4.33K ﹤0.01% 2706
2025
Q3 		$24.1K Hold
18,359
– – ﹤0.01% 2969
2025
Q2 		$13.2K Sell
18,359
-231,913
-93% -$182K ﹤0.01% 3178
2025
Q1 		$368K Sell
250,272
-170,414
-41% -$406K ﹤0.01% 2494
2024
Q4 		$1.86M Buy
420,686
+11,764
+3% +$47.7K ﹤0.01% 2003
2024
Q3 		$1.68M Sell
408,922
-349
-0.1% -$1.88K ﹤0.01% 2046
2024
Q2 		$2.67M Buy
409,271
+12,664
+3% +$89.6K ﹤0.01% 1814
2024
Q1 		$3.45M Buy
396,607
+3,379
+0.9% +$41K ﹤0.01% 1694
2023
Q4 		$4.5M Sell
393,228
-1,881
-0.5% -$18.6K ﹤0.01% 1568
2023
Q3 		$3.8M Sell
395,109
-5,218
-1% -$51.1K ﹤0.01% 1587
2023
Q2 		$4.26M Buy
400,327
+2,662
+0.7% +$28.6K ﹤0.01% 1539
2023
Q1 		$4.18M Buy
397,665
+3,102
+0.8% +$34.7K ﹤0.01% 1513
2022
Q4 		$4.89M Buy
394,563
+1,738
+0.4% +$19.7K ﹤0.01% 1417
2022
Q3 		$4.07M Sell
392,825
-48,146
-11% -$546K ﹤0.01% 1462
2022
Q2 		$5.08M Buy
440,971
+302,371
+218% +$3.56M ﹤0.01% 1403
2022
Q1 		$1.74M Buy
138,600
+768
+0.6% +$8.8K ﹤0.01% 2046
2021
Q4 		$1.61M Buy
137,832
+278
+0.2% +$3.41K ﹤0.01% 2108
2021
Q3 		$1.8M Buy
137,554
+30,007
+28% +$388K ﹤0.01% 2071
2021
Q2 		$1.38M Sell
107,547
-1,421
-1% -$16.3K ﹤0.01% 2110
2021
Q1 		$1.22M Buy
108,968
+426
+0.4% +$4.5K ﹤0.01% 2140
2020
Q4 		$1.24M Buy
108,542
+21,613
+25% +$237K ﹤0.01% 2051
2020
Q3 		$782K Sell
86,929
-6,942
-7% -$69K ﹤0.01% 2098
2020
Q2 		$968K Buy
93,871
+1,028
+1% +$10.5K ﹤0.01% 1990
2020
Q1 		$937K Sell
92,843
-4,572
-5% -$53.7K ﹤0.01% 1868
2019
Q4 		$1.3M Buy
97,415
+23,068
+31% +$254K ﹤0.01% 1973
2019
Q3 		$638K Buy
74,347
+7,656
+11% +$74.4K ﹤0.01% 2121
2019
Q2 		$730K Sell
66,691
-9,770
-13% -$109K ﹤0.01% 2053
2019
Q1 		$866K Buy
76,461
+1,140
+2% +$12.7K ﹤0.01% 2007
2018
Q4 		$653K Buy
75,321
+15,708
+26% +$180K ﹤0.01% 2046
2018
Q3 		$921K Hold
59,613
– – ﹤0.01% 1979
2018
Q2 		$955K Sell
59,613
-2,674
-4% -$39.6K ﹤0.01% 1936
2018
Q1 		$805K Sell
62,287
-10,896
-15% -$136K ﹤0.01% 1975
2017
Q4 		$922K Buy
73,183
+6,669
+10% +$87.1K ﹤0.01% 1905
2017
Q3 		$879K Buy
66,514
+9,473
+17% +$130K ﹤0.01% 1917
2017
Q2 		$900K Buy
57,041
+2,704
+5% +$39.3K ﹤0.01% 1863
2017
Q1 		$781K Sell
54,337
-715
-1% -$9.78K ﹤0.01% 1891
2016
Q4 		$704K Buy
55,052
+16,012
+41% +$202K ﹤0.01% 1873
2016
Q3 		$509K Sell
39,040
-886
-2% -$10.4K ﹤0.01% 1687
2016
Q2 		$434K Hold
39,926
– – ﹤0.01% 1396
2016
Q1 		$362K Buy
39,926
+9,049
+29% +$74.6K ﹤0.01% 1466
2015
Q4 		$302K Hold
30,877
– – ﹤0.01% 1556
2015
Q3 		$263K Buy
30,877
+2,190
+8% +$20.4K ﹤0.01% 1571
2015
Q2 		$283K Buy
28,687
+3,773
+15% +$43.9K ﹤0.01% 1564
2015
Q1 		$342K Buy
24,914
+4,075
+20% +$53.5K ﹤0.01% 1417
2014
Q4 		$267K Sell
20,839
-475
-2% -$5.44K ﹤0.01% 1435
2014
Q3 		$238K Buy
+21,314
New +$244K ﹤0.01% 1423

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Legal & General Group's IRWD Position: Q1 2026 in Review

Legal & General Group reduced its Ironwood Pharmaceuticals (IRWD) stake by 14% in Q1 2026, selling an estimated $9.85K and leaving 14,288 shares worth $50.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2681.

Legal & General Group first reported a position in IRWD in Q3 2014 and has held it in 47 quarters since. The position peaked at $5.08M in Q2 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Legal & General Group held 14,288 shares of Ironwood Pharmaceuticals worth $50.2K as of Q1 2026.
  • Legal & General Group sold 2,402 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $9.85K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2681 holding.
  • Legal & General Group first reported a position in Ironwood Pharmaceuticals in Q3 2014 and has held it in 47 quarters since.
  • Legal & General Group's Ironwood Pharmaceuticals position peaked at $5.08M in Q2 2022.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.